Every open market buy and sale of BioAge Labs, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $7.8M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when BIOA insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an BIOA officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every BIOA insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Shane BartonPrincipal Accounting Officer | Sale plan | 62,566 | $25.20 | $1.6M | 0 | Jul 1Form 4 |
| Apr 1, 2026 | Paul D RubinChief Medical Officer | Sale plan | 8,820 | $17.81 | $157K | 0 | Apr 3Form 4 |
| Mar 2, 2026 | Paul D RubinChief Medical Officer | Sale plan | 7,433 | $20.30 | $151K | 0 | Mar 3Form 4 |
| Feb 2, 2026 | Paul D RubinChief Medical Officer | Sale plan | 7,433 | $18.75 | $139K | 0 | Feb 3Form 4 |
| Jan 13, 2026 | Dov A Goldstein MdCFO | Sale plan | 27,000 | $19.70 | $532K | 22,408 | Jan 15Form 4 |
| Jan 13, 2026 | Kristen FortneyCEO | Sale plan | 233,107 | $18.12 | $4.2M | 976,949 | Jan 15Form 4 |
| Jan 2, 2026 | Paul D RubinChief Medical Officer | Sale plan | 7,433 | $12.85 | $96K | 0 | Jan 6Form 4 |
| Dec 9, 2025 | Paul D RubinChief Medical Officer | Sale plan | 18,000 | $12.00 | $216K | 0 | Dec 11Form 4 |
| Dec 4, 2025 | Paul D RubinChief Medical Officer | Sale plan | 68,897 | $10.19 | $702K | 0 | Dec 5Form 4 |
BIOA insider trading FAQ
Are BIOA insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of BIOA on the open market in 0 trades, and 4 sold $7.8M in 9 trades, 100% of that under pre-arranged trading plans.
When did an BIOA insider last buy shares?
There has been no open market insider purchase of BIOA in the last two years.
When did an BIOA insider last sell shares?
Shane Barton (Principal Accounting Officer) sold 62,566 shares for $1.6M on Jun 30, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
